Amal Kaddoumi is a Professor of Neuropharmacology in the Department of Drug Discovery and Development at Harrison College of Pharmacy, Auburn University. Dr. Kaddoumi's research interest is in translational and experimental therapeutics that include drug discovery and development, identification of novel therapeutic targets, and translational research devoted to finding therapies for neurodegenerative diseases, including Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA). Her primary research goals are to investigate cerebrovascular dysfunction's contribution to the pathogenesis of AD and CAA and to develop therapeutic strategies to restore the AD-associated dysfunctional blood–brain barrier (BBB) and improve cognitive function.